Roche
Market Access/ News/ News/ Novartis/ Roche
Breakthrough designation for Roche/Novartis’ Xolair in food allergies
AstraZeneca/ News/ Pfizer/ Roche
Drug firms fight US government’s Iraq corruption probe
Joy Persaud
litigation
0 Comment
US Department of Justice investigating J&J, Pfizer, Roche and others
News/ News/ R&D/ Roche/ Top pharmaceutical companies/ UK & Europe
New Huntington’s drug granted priority designation
Joy Persaud
European Medicines Agency, Huntington's disease, Roche
0 Comment
News/ News/ R&D/ Roche/ Top stories
Roche’s MS drug Ocrevus earns blockbuster status a year after launch
Bristol-Myers Squibb/ Market Access/ News/ News/ News/ Novo Nordisk/ Patients/ Pfizer/ Roche/ Top stories
Pfizer backed off, but the price hike game continues
Piotr Wnuk
cancer, Diabetes, Donald Trump, pricing
0 Comment
Roche to file Tecentriq in triple negative breast cancer
Richard Staines
breast cancer, Bristol-Myers Squibb, cancer, Merck & Co, Roche
0 Comment
No other immunotherapies are approved in indication
Market Access/ News/ News/ News/ Oncology/ Roche/ Top stories/ UK & Europe
NICE okays Roche rare lung cancer drug after price cut
Richard Staines
cancer, lung cancer, Pfizer, Roche
0 Comment
Alecensa has aced Pfizer’s rival in head-to-head trial
Market Access/ News/ News/ Roche/ UK & Europe
NICE okays NHS funding for MS and eczema drugs
Richard Staines
atopic dermatitis, multiple sclerosis, NICE, Roche, Sanofi
0 Comment